A 4-variable model to predict cardio-kidney events and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Luís Carlos Ferreira Mendonça

    Autor

  • João Sérgio De Lima Soares Neves

    Autor

  • Paulo Manuel Barreiros De Castro Chaves

    Autor

  • João Pedro Melo Marques Pinho Ferreira

    Autor

Participantes de fora da FMUP

  • Vieira, MB

Unidades de investigação

Abstract

IntroductionCurrent prognostic models for CKD are complex and were designed to predict one single outcome. We aimed to develop and validate a simple and parsimonious prognostic model to predict cardio-kidney events and mortality.MethodsPatients from the CRIC Study (n=3718) were randomly divided into derivation (n=2478) and validation (n=1240) cohorts. Twenty-nine candidate variables were pre-selected. Multivariable Cox regression models were developed using stepwise selection for various cardio-kidney endpoints, namely: i) the primary composite outcome of 50% decline in eGFR from baseline, end-stage renal disease or cardiovascular mortality; ii) hospitalization for heart failure (HHF) or cardiovascular mortality; iii) 3-point major CV endpoints (3P-MACE); iv) all-cause death.ResultsDuring a median follow-up of 9 years, the primary outcome occurred in 977 patients of the derivation cohort and 501 patients of the validation cohort. Log-transformed NT-proBNP, log-transformed hs-cTnT, log-transformed albuminuria and eGFR were the dominant predictors. The primary outcome risk score discriminated well (c-statistic=0.83) with a proportion of events of 11.4% in the lowest tertile of risk and 91.5% in the highest tertile at 10 years. The risk model presented good discrimination for HHF or cardiovascular mortality, 3P-MACE and all-cause death (c-statistic=0.80, 0.75 and 0.75, respectively). The 4-variable risk model achieved similar c-statistics for all tested outcomes in the validation cohort. The discrimination of the 4-variable risk model was mostly superior to that of published models.ConclusionThe combination of NT-proBNP, hs-cTnT, albuminuria and eGFR in a single 4-variable model provides a unique individual prognostic assessment of multiple cardio-kidney outcomes in CKD.

Dados da publicação

ISSN/ISSNe:
1421-9670, 0250-8095

American Journal of Nephrology  S. Karger AG

Tipo:
Article
Páginas:
391-398
Link para outro recurso:
www.scopus.com

Citações Recebidas na Scopus: 5

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Albuminuria; Biomarkers; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Renal Insufficiency, Chronic; albumin; aldosterone; amino terminal pro brain natriuretic peptide; bilirubin; low density lipoprotein cholesterol; troponin T; uric acid; biological marker; brain natriuretic peptide; peptide fragment; adult; albuminuria; Article; atrial fibrillation; cardiovascular mortality; cerebrovascular accident; chronic kidney failure; clinical article; cohort analysis; congestive heart failure; creatinine blood level; diabetes mellitus; end stage renal disease; enzyme linked immunosorbent assay; estimated glomerular filtration rate; female; follow up; heart failure; heart infarction; heart rate; hospitalization; human; kidney function; middle aged; mortality; predictive value; regression model; revascularization; risk assessment; risk model; systolic blood pressure; validation process; complication; controlled study; heart fail

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023

Microvascular Ocular Changes of Systemic Lupus Erythematous (VascLup) - NCT05890313

Investigador Principal: André Ferreira

Estudo Observacional Académico (VascLup) . 2023

Predictors of readmission and mortality in patients with decompensated heart failure according to glycaemic status

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Glycaemic status) . 2023

Association of Glycemic Variability and Time in Range with Lipid Profile in Type 1 Diabetes

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Glycemic Variability) . 2023

Time in Range and Complications of Diabetes: a Cross-Sectional Analysis of patients with Type 1 Diabetes

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Type 1 Diabetes) . 2023

FGF23 effects within the vasculature: more insights into Atherosclerosis?

Investigador Principal: Paulo Manuel Barreiros de Castro Chaves

Estudo Clínico Académico (FGF23) . 2020

Evaluation of thyroid function in patients hospitalized for acute heart failure

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Heart failure) . 2021

Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis

Investigador Principal: Paulo Manuel Barreiros de Castro Chaves

Estudo Clínico Académico . 2021

Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2021

Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2022

Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Hydrodistension ) . 2022

Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2022

Insights into Acute Ischemic Stroke Prognostic Factors in Patients with Mechanical Heart Valves

Investigador Principal: Paulo Manuel Barreiros de Castro Chaves

Estudo Clínico Académico . 2022

Relaxin and HFpEF: unveiling a new contributor to personalized medicine?

Investigador Principal: Paulo Manuel Barreiros de Castro Chaves

Estudo Clínico Académico . 2023

Clinical prediction rules in the prognosis of cerebral hemorrhage: Prognostication of mortality and functional recovery

Investigador Principal: Paulo Manuel Barreiros de Castro Chaves

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação